Home/Filings/4/0001387131-21-008750
4//SEC Filing

Ling Karen 4

Accession 0001387131-21-008750

CIK 0000025743other

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 4:31 PM ET

Size

5.2 KB

Accession

0001387131-21-008750

Insider Transaction Report

Form 4
Period: 2021-08-17
Ling Karen
Director
Transactions
  • Purchase

    Common Stock

    2021-08-17$0.75/sh+33,445$25,084130,309 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions with prices ranging from $0.746 to $0.748 for an average weighted purchase price of $0.75. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

1 file

Issuer

TherapeuticsMD, Inc.

CIK 0000025743

Entity typeother

Related Parties

1
  • filerCIK 0001597450

Filing Metadata

Form type
4
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 4:31 PM ET
Size
5.2 KB